Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.
Endocrine Service, Division of General Medicine, Department of Medicine, and Medical Library-Nathan Cummings Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. robbinsr@mskcc.org
Richard J
RJ
Robbins
Anne K
AK
Robbins
D000818:Animals; D013956:Antithyroid Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000628:therapy*; D013972:Thyrotropin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin